Skip to main content
. 2021 Oct 5;22(6):819. doi: 10.3892/ol.2021.13080

Table IV.

Target genes controlled by ≥3 miRNAs among the differentially expressed genes in patients with non-pCR and breast cancer recurrence.

Target gene miRNAs
BCL2 hsa-miR-195-5p, hsa-miR-16-5p, hsa-miR-34b-3p
CCND1 hsa-miR-106b-5p, hsa-miR-195-5p, hsa-miR-16-5p, hsa-let-7f-5p
CDK6 hsa-miR-195-5p, hsa-miR-16-5p, hsa-miR-34b-3p
MET hsa-miR-31-5p, hsa-miR-34b-3p, hsa-miR-7515
VEGFA hsa-miR-106b-5p, hsa-miR-195-5p, hsa-miR-16-5p, hsa-miR-34b-3p, had-miR-133a-3p
WEE1 hsa-miR-106b-5p, hsa-miR-195-5p, hsa-miR-16-5p

miRNA/miR, microRNA; pCR, pathological complete response; CCND1, G1/S-specific cyclin-D1; WEE1, Wee1-like protein kinase.